%0 Journal Article
%T Sentinel Node Biopsy for Nonmelanoma Skin Cancer of the Head and Neck.
%A Sethi R
%A Emerick K
%J Otolaryngol Clin North Am
%V 54
%N 2
%D Apr 2021
%M 33743888
%F 1.866
%R 10.1016/j.otc.2020.11.005
%X Sentinel lymph node biopsy has the potential to impact regional control and survival for high-risk cutaneous malignancy. The outcome of sentinel lymph node biopsy is a potential guide for treatment and surveillance. The population of high-risk nonmelanoma patients that will benefit from sentinel lymph node biopsy remains to be determined. Any cutaneous malignancy with a greater than 10% risk of occult metastasis should be considered for sentinel lymph node biopsy or active surveillance. Localized cutaneous squamous cell carcinoma lesions with multiple high-risk features and nearly all patients with localized Merkel cell carcinoma should be considered for sentinel lymph node biopsy.